· rebuilt nightly from public records
Signal Sheet
Durham, North Carolina is home to Pelthos Therapeutics, a publicly listed biological products, (no diagnostic substances) company, founded 2021. It raised $18M in Nov 2025 and its filings name 9 officers. Everything below links to the record it came from.
The easy button for new customers
Lakewave's AI keeps accounts like this one coming. Your pipeline refills while you sleep.
Every night it scans funding, filings, new officers, hiring, contracts, permits and bids, finds the accounts that fit what you sell, and delivers each with outreach and a pursuit plan. Just need a list? Its AI waterfall builds one with verified, reachable contacts.
The roles that matter for a seller right now. Names on this page come from SEC filings or the company's own announcements. Contacts you find with a free trial are verified before you see them. How we source names
| Role | Contact | Source | Why they matter now |
|---|---|---|---|
| Executive Officer | Scott Plesha | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Francis Knuettel II | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Executive Officer | Sai Rangarao | SEC filing, Nov 2025 | Named officer in the filing; part of the buying group |
| Chief Technology Officer | Richard Baxter | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Peter Greenleaf | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Ezra Friedberg | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Todd Davis | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Richard Malamut | SEC filing, Nov 2025 | Technology and tooling decisions |
| Chief Technology Officer | Matthew Pauls | SEC filing, Nov 2025 | Technology and tooling decisions |
Signed a material agreement
Corporate eventOfficer or director change
New leadershipEquity raise reported to the SEC, Nov 2025. Money arrives before the spending plan does.
CapitalThe most recent events first, refreshed every night. Each links to the record it came from.
| When | What happened | Kind | Source |
|---|---|---|---|
| Oct 30, 2026 | Signed a material agreement | Corporate event | SEC filing |
| Oct 30, 2026 | Officer or director change | New leadership | SEC filing |
| Sep 29, 2026 | Officer or director change | New leadership | SEC filing |
| Nov 6, 2025 | Raised $18M in equity from 8 investors | Capital | SEC filing |
| Jul 1, 2025 | Raised $50.1M in equity from 13 investors | Capital | SEC filing |
Lakewave finds the right people at Pelthos Therapeutics, checks every address against the mail server before you see it, and drafts a first email for each, which you review and send from your own inbox.
Try it on Pelthos Therapeutics with a free trial →| Headquarters | Durham, North Carolina, per the filing address |
| Industry group | Biological Products, (No Diagnostic Substances) |
| Founded | 2021, NV |
| Ownership | Listed company |
| Raise history | $50.1M (Jul 2025) · $18M (Nov 2025) |
| Lakewave Rising | 32 · 2 kinds of evidence · rank in North Carolina after sign-up |
Private-sector companies in the same industry group and state, ranked by Rising score.
Yes. Pelthos Therapeutics reported a $18M equity raise to the SEC on Nov 6, 2025 with 8 investors.
The company's SEC filing, Nov 2025 names Scott Plesha (Executive Officer) among its officers.
Durham, North Carolina, per the address on its SEC filing.
Select the accounts and territory you sell to and get dated reasons for every company: new budget, new leaders, new hires, with who to reach and a first draft for each contact.
Start your free trialCompiled from public records and refreshed nightly; last updated Nov 16, 2026. Facts are as the SEC, the company's careers page or the company's own announcements published them. Check the source before acting. See something wrong? Tell us and we will correct it.